2017
DOI: 10.1007/s00277-017-2933-x
|View full text |Cite
|
Sign up to set email alerts
|

Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia

Abstract: The development of acute myeloid leukemia (AML) in patients with untreated chronic lymphocytic leukemia (CLL) is rare. We experienced a 65-year-old man who developed AML with aberrant CD7 expression and monoallelic CEBPA mutation during watchful waiting for CLL. He failed to achieve complete response (CR) by standard induction therapy for AML. We retrospectively reviewed 27 patients who developed AML with untreated CLL published between 1973 and 2016. The median age at diagnosis of AML was 68 years, and the me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 35 publications
1
15
0
1
Order By: Relevance
“…However, only tens of CLL concurrent with other hematologic malignancies have been described since 1970s (5)(6)(7). Currently, the development of subsequent multiple myeloma in patients with untreated CLL is generally diagnosed as therapy-related, and the prognosis of those patients is always inferior to that of de novo cases (8). Thus, the comprehensive reveal of diagnosis and clinical features of CLL patients concurrent with other hematologic malignancies is critical for the improvement of their survival rate.…”
Section: Introductionmentioning
confidence: 99%
“…However, only tens of CLL concurrent with other hematologic malignancies have been described since 1970s (5)(6)(7). Currently, the development of subsequent multiple myeloma in patients with untreated CLL is generally diagnosed as therapy-related, and the prognosis of those patients is always inferior to that of de novo cases (8). Thus, the comprehensive reveal of diagnosis and clinical features of CLL patients concurrent with other hematologic malignancies is critical for the improvement of their survival rate.…”
Section: Introductionmentioning
confidence: 99%
“…AML is about 10 to 50 times more frequent in CLL patients than in the agematched general population. In one report, eleven patients developed AML during the course of untreated CLL, whereas AML and CLL were diagnosed concomitantly in 16 patients [10]. The concomitant occurrence of AML and CLL might stem from a common stem cell defect, leukomogenic factors or from a genetic predisposition in some patients.…”
Section: Discussionmentioning
confidence: 99%
“…7,8,12 Opisuju se i rijetki slučajevi pojave AML-a u bolesnika s KLL-om. [13][14][15][16] Nekoliko je hipoteza o istodobnoj pojavi KLL-a i AML-a ili MDS-a. Neki smatraju da je moguća slučajna pojava dviju bolesti koje se relativno često javljaju u starijoj dobi.…”
Section: Raspravaunclassified